Synektik Spólka Akcyjna (SNT.WA)
PLN 184.4
(-1.91%)
PLN 184.4
(-1.91%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 83.04 Million PLN | 29.84% |
| 2023 | 63.96 Million PLN | 72.76% |
| 2022 | 36.24 Million PLN | 87.48% |
| 2021 | 19.33 Million PLN | 7.75% |
| 2020 | 17.94 Million PLN | -9.17% |
| 2019 | 19.75 Million PLN | -5.13% |
| 2018 | 20.82 Million PLN | 89.95% |
| 2017 | 10.96 Million PLN | 28.39% |
| 2016 | 8.53 Million PLN | -17.93% |
| 2015 | 10.4 Million PLN | -1.17% |
| 2014 | 10.52 Million PLN | -50.82% |
| 2013 | 21.4 Million PLN | 23.54% |
| 2012 | 17.32 Million PLN | 44.41% |
| 2011 | 11.99 Million PLN | 46.75% |
| 2010 | 8.17 Million PLN | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 19.22 Million PLN | -3.97% |
| 2024 Q3 | 22.49 Million PLN | 28.81% |
| 2024 Q2 | 17.46 Million PLN | -9.17% |
| 2023 Q2 | 13.86 Million PLN | 16.99% |
| 2023 Q4 | 20.01 Million PLN | 24.72% |
| 2023 FY | 62.61 Million PLN | 72.76% |
| 2023 Q3 | 16.04 Million PLN | 15.78% |
| 2023 Q1 | 11.84 Million PLN | 7.88% |
| 2022 Q2 | 8.01 Million PLN | 27.69% |
| 2022 Q4 | 10.98 Million PLN | 6.6% |
| 2022 FY | 36.24 Million PLN | 87.48% |
| 2022 Q1 | 6.27 Million PLN | 56.88% |
| 2022 Q3 | 10.3 Million PLN | 28.59% |
| 2021 Q3 | 5.85 Million PLN | 37.85% |
| 2021 Q2 | 4.24 Million PLN | -5.95% |
| 2021 Q1 | 4.51 Million PLN | 54.12% |
| 2021 FY | 19.33 Million PLN | 7.75% |
| 2021 Q4 | 4 Million PLN | -31.68% |
| 2020 FY | 17.94 Million PLN | -9.17% |
| 2020 Q4 | 2.93 Million PLN | -33.11% |
| 2020 Q1 | 5.37 Million PLN | 118.22% |
| 2020 Q2 | 4.62 Million PLN | -13.94% |
| 2020 Q3 | 4.38 Million PLN | -5.35% |
| 2019 Q1 | 4.11 Million PLN | 24.28% |
| 2019 FY | 19.75 Million PLN | -5.13% |
| 2019 Q4 | 2.46 Million PLN | -49.92% |
| 2019 Q3 | 4.92 Million PLN | 1.07% |
| 2019 Q2 | 4.86 Million PLN | 18.38% |
| 2018 Q3 | 3.34 Million PLN | 14.16% |
| 2018 FY | 20.82 Million PLN | 89.95% |
| 2018 Q1 | 2.89 Million PLN | 19.72% |
| 2018 Q2 | 2.93 Million PLN | 1.45% |
| 2018 Q4 | 3.3 Million PLN | -1.21% |
| 2017 FY | 10.96 Million PLN | 28.39% |
| 2017 Q1 | 51.02 Thousand PLN | -98.31% |
| 2017 Q2 | 2.49 Million PLN | 4789.15% |
| 2017 Q3 | 2.97 Million PLN | 19.24% |
| 2017 Q4 | 2.41 Million PLN | -18.79% |
| 2016 Q1 | 2.24 Million PLN | -10.74% |
| 2016 Q4 | 3.02 Million PLN | 62.75% |
| 2016 Q3 | 1.86 Million PLN | -25.15% |
| 2016 Q2 | 2.48 Million PLN | 10.59% |
| 2016 FY | 8.53 Million PLN | -17.93% |
| 2015 Q1 | -3.64 Million PLN | -176.12% |
| 2015 FY | 10.4 Million PLN | -1.17% |
| 2015 Q2 | 2.43 Million PLN | 166.74% |
| 2015 Q4 | 2.51 Million PLN | -20.54% |
| 2015 Q3 | 3.16 Million PLN | 30.1% |
| 2014 Q2 | 5.3 Million PLN | -15.1% |
| 2014 Q1 | 6.24 Million PLN | 21.75% |
| 2014 Q3 | 6.29 Million PLN | 18.66% |
| 2014 Q4 | 4.79 Million PLN | -23.79% |
| 2014 FY | 10.52 Million PLN | -50.82% |
| 2013 Q2 | 4.59 Million PLN | -8.4% |
| 2013 Q4 | 5.12 Million PLN | -5.59% |
| 2013 FY | 21.4 Million PLN | 23.54% |
| 2013 Q3 | 5.43 Million PLN | 18.32% |
| 2013 Q1 | 5.01 Million PLN | 7.95% |
| 2012 Q3 | 3.9 Million PLN | 3.9% |
| 2012 Q4 | 4.64 Million PLN | 18.86% |
| 2012 Q2 | 3.76 Million PLN | 0.0% |
| 2012 FY | 17.32 Million PLN | 44.41% |
| 2011 FY | 11.99 Million PLN | 46.75% |
| 2010 FY | 8.17 Million PLN | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Adiuvo Investments S.A. | 6.05 Million PLN | -1271.538% |
| Genomtec S.A. | 7.93 Million PLN | -946.719% |
| Medinice S.A. | -5.7 Million PLN | 1555.937% |
| Medicalgorithmics S.A. | 16.52 Million PLN | -402.704% |